Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 24, 2014
MRC Technology, a medical research charity, and Yabao Pharmaceutical Co, Inc., a leading pharmaceutical company in China, today announced an exclusive license agreement to discover, develop and commercialise innovative compounds targeting a specific ...
read more
Wednesday, September 06, 2017
mProve Health and Greenphire announced a partnership to provide patients with real-time access to ClinCard payment details via mProve’s engagement app, mPal.
read more
Wednesday, December 16, 2020
Mesquite, TX MPM Medical is voluntarily recalling one lot of Regenecare HA Hydrogel to the consumer level.
read more
MPI Research, the largest single-site preclinical/early clinical contract research organization (CRO) globally, is pleased to announce a strategic partnership with inviCRO and 3D Imaging to unite world-class molecular imaging, radiochemistry, and ...
read more
MPI Research and Exemplar Genetics today announced the first successful validation of a new genetically engineered miniature pig model, offering an attractive alternative to rodent models, of atherosclerosis. The ExeGen® LDLR miniswine is a pig model...
read more
Motion Industries has opened its new distribution center in Auburn, WA.
read more
Tuesday, October 08, 2024
Mosaic Therapeutics, Ltd, a targeted oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, today announced the appointment of Dr Barry Davies as CSO, where he will lead the Company’s...
read more
Morphotek®, Inc., a subsidiary of Eisai Inc., has announced the launch of its Antibody Drug Conjugate (ADC) Services business based on its proprietary REsidue-SPEcific Conjugation TechnologyTM (RESPECTTM) and eribulin-linker toxin platforms.
read more
Wednesday, September 06, 2017
Morphotek, a subsidiary of Eisai, has entered into a collaboration and license agreement with Fujirebio Diagnostics to validate and commercialize the CA125 II assay for use on the Lumipulse Instrument System.
read more
Wednesday, April 03, 2013
The new Secura laboratory balance developed by Sartorius for applications in regulated areas such as pharmaceutical labs fulfills particularly high reliability requirements. The balance monitors its ambient conditions automatically, thereby ...
read more
CHICAGO (AP) — For the first time, a major study shows that a drug targeting the body's disease-fighting immune system may improve survival for the most common form of lung cancer
read more
Monash University and ClinChoice announced a strategic partnership designed to fast-track early-phase clinical trials and bring groundbreaking health innovations and discoveries closer to patients worldwide.
read more
Mologic and BioSure are working together to produce a COVID-19 antibody self-test.
read more
Harbour BioMed has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167.
read more
Friday, February 05, 2021
Moleculin Biotech has signed an agreement with Catalyst to manage its US clinical trial to study the ability of Annamycin to treat soft tissue sarcoma that has metastasized to the lungs.
read more